The value of MRI in the diagnosis and management of neurocysticercosis

Singapore Medical Journal

Volumn 41, Issue 3, 2000, Pages 132-134

  Ng, S H ^a,b   Tan, T Y ^c   Fock, K M ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

^b TUEN MUN HOSPITAL   (Hong Kong)

^c NONE

Author keywords

Antihelminthic therapy; CT scan; Epilepsy; MRI; Neurocysticercosis

Indexed keywords

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOGRAPHY;

ADULT; BRAIN DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034152126     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Davis LE, Kornfeld M. Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. Eur Neurol 1991; 31:229-40.
2. Sotelo J, Del Brutto OH, Roman GC. Cysticercosis. Current clinical topics in infectious diseases, Vol 16. Edited by Remington JS, Swartz MN. Cambridge: Blackwell Science; 1996:240-59.
3. Wadia NH. Neurocysticercosis. Tropical Neurology. Edited by Shakir RA, Newman PK, Poser CM. London: WB Saunders Co; 1996:247-73.
4. McCormick G, Zee C, Heiden J. Cysticercosis Cerebri. Arch Neurol 1978; 39:534-9.
5. Del Brutto OH. Neurocysticercosis. Curr Opin Neurol 1997; 10:268-72.
6. Richards F Jr, Schantz PM. Laboratory diagnosis of cysticercosis. Clin Lab Med 1991; 11:1011-28.
7. Kramer LD, Locke GE, Byrd SE, Daryabagi J. Cerebral Cysticercosis: Documentation of Natural History with CT. Radiology 1989; 171:459-62.
8. Lotz J, Hewlett R, Albeit B, Bowen R. Neurocysticercosis: correlative pathomorphology and MR imaging. Neuroradiology 1988; 30:35-41.
9. Suss RA, Maravilla KR, Thompson J. MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. AJNR 1986; 7:235-42.
10. Spickler EM, Lufkin RB, Teresi L, Lanman T, Levegue M, Benston JR. High signal intraventricular cysticercosis on T1 weighted MR imaging. AJNR 1989; 10:S64.
11. Chang K-H, Lee JH, Han MH, Han MC. The role of contrast-enhanced MR imaging in the diagnosis of neurocysticercosis. AJNR 1991; 128:509-12.
12. Kramer LD. Medical treatment of Cysticercosis - Ineffective. Arch Neurol 1995; 52:101-2.
13. Sotelo J, Del Brutto OH, Penagos P, Escobado F, Torres B, Rodriguez, Carbajal J, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 1990; 237:69-72.
14. Corona T, Lugo R, Medina R, Sotelo J. Single-day praziquantel therapy for neurocysticercosis [letter]. N Engl J Med 1996; 334:125.
15. Jung H, Hurtado M, Sanchez M, Medina MT, Sotelo J. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. Clin Neuropharmacol 1990; 13:559-64.
16. Garg RK, Agrawal A. Medical treatment for cysticercosis [letter]. Arch Neurol 1996; 53:295.
17. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992; 42:389-92.
18. Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992; 327:696-701.
19. Cruz I, Cruz ME, Carrasco F, Horton J. Neurocysticercosis: optimal dose treatment with albendazole. J Neurol Sci 1995; 133:152-4.
20. Del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 1994; 44:1706-9.